The American Journal of Surgery
Volume 198, Issue 4 , Pages 511-515 , October 2009

Factors associated with improved outcome after surgery in metastatic breast cancer patients

Received 31 March 2009 ,Revised 14 June 2009

References 

  1. Khan S, Stewart A, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer?. Surgery. 2002;132:620–627
  2. Rao R, Feng L, Kuerer H, et al. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol. 2008;6:1696–1702
  3. Gnerlich J, Jeffe D, Deshpane A, et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol. 2007;14:2187–2194
  4. Demicheli R, Valagussa P, Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases?. Br J Cancer. 2001;85:490–492
  5. Retsky M, Bonadonna G, Demecheli R, et al. Hypothesis: induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res. 2004;6:372–374
  6. Hormbrey E, Han C, Roberts A, et al. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res. 2003;9:4332–4339
  7. O'Reilly M, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315–328
  8. Fields R, Jeffe D, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol. 2007;14:3345–3351
  9. Flanigan R, Salmon S, Blumenstein B, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345:1655–1659
  10. Dauplat J, Le Bouedec G, Pomel C, et al. Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol. 2000;19:42–48
  11. Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 2003;197:233–241
  12. Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 2004;136:650–659
  13. Doglietto G, Pacelli F, Caprino P, et al. Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg. 1999;65:352–355
  14. Danna E, Sinha P, Gilbert M, et al. Surgical removal of the primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004;64:2205–2211
  15. Rastogi P, Andersen SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008;26:778–785

PII: S0002-9610(09)00355-9

doi: 10.1016/j.amjsurg.2009.06.011

The American Journal of Surgery
Volume 198, Issue 4 , Pages 511-515 , October 2009

Article Tools

* Image Usage & Resolution